`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`
`HOPEWELL PHARMA VENTURES, INC.,
`Petitioner
`v.
`MERCK SERONO S.A.,
`Patent Owner
`
`___________________
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`___________________
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`PETITIONER HOPEWELL PHARMA VENTURES, INC.’S NOTICE OF
`REMOTE DEPOSITION OF FRED D. LUBLIN, M.D.
`
`
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`Counsel for the parties have conferred and agreed that Petitioner, Hopewell
`
`Pharma Ventures, Inc. (“Petitioner”), will conduct cross-examination by deposition
`
`of Patent Owner’s witness at the date and time indicated below.
`
`The cross-examination will be conducted remotely using video
`
`teleconferencing service(s) and/or telephony service(s) that provide remote access
`
`for authorized parties wishing to participate in the deposition via the Internet
`
`and/or telephonically.
`
`Date/Time:
`
`Declarant’s Name:
`
`
`
`Tuesday, March 5, 2024, at 9:00 am ET
`
`Fred D. Lublin, M.D.
`
`Location:
`
`Dr. Lublin and the other parties participating in the
`
`deposition, including the examining attorneys, the
`
`defending attorneys, and the court reporter, will be
`
`participating from various geographic locations.
`
`The cross-examination will be recorded stenographically by a court reporter
`
`authorized by law to administer oaths. It will also be transcribed by real-time
`
`reporting software and may be recorded by video.
`
`- 1 -
`
`
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX PLLC
`
`/Eldora L. Ellison/
`
`Eldora L. Ellison, Ph.D., Esq.
`Registration No. 39,967
`Lead Attorney for Petitioner
`
`Date: February 16, 2024
`1101 K Street, NW, 10th Floor
`Washington, DC 20005
`(202) 371-2600
`
`
`- 2 -
`
`
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`I certify that the above-captioned PETITIONER HOPEWELL PHARMA
`
`VENTURES, INC.’S NOTICE OF REMOTE DEPOSITION OF FRED D.
`
`LUBLIN, M.D. was served in its entirety on February 16, 2024, upon the
`
`following parties via electronic mail:
`
`Emily R. Whelan (Lead Counsel) Emily.Whelan@wilmerhale.com
`Deric Geng (Back-up Counsel) Deric.Geng@wilmerhale.com
`Cindy Kan (Back-up Counsel) Cindy.Kan@wilmerhale.com
`David B. Bassett (Back-up Counsel) David.Bassett@wilmerhale.com
`Vinita Ferrera (Back-up Counsel) Vinita.Ferrera@wilmerhale.com
`David Mlaver (Back-up Counsel) David.Mlaver@wilmerhale.com
`Mary.Pheng (Back-up Counsel) Mary.Pheng@wilmerhale.com
`Asher McGuffin (Back-up Counsel) Asher.McGuffin@wilmerhale.com
`WILMER CUTLER PICKERING HALE AND DORR LLP
`WHMerckMavencladIPRs@wilmerhale.com
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX PLLC
`
`/Eldora L. Ellison/
`
`Eldora L. Ellison, Ph.D., Esq.
`Registration No. 39,967
`Lead Attorney for Petitioner
`
`Date: February 16, 2024
`1101 K Street, NW, 10th Floor
`Washington, DC 20005
`(202) 371-2600
`
`
`21759739.1
`
`
`
`